XenoPort, Inc.

Nathalie Moll, currently secretary general of the European Association for Bioindustries,has been appointed EFPIA's director general – effective April, 2017. Eric Cornut will continue to lead EFPI

FDA is again being pulled into the drug pricing debate, this time by insurance companies with a report suggests that drugmakers may be exploiting orphan drug designation for economic gain with the non

The Pink Sheet regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between May 21-June

IN VITRO DIAGNOSTICS Mergers & Acquisitions Luminex Corp. Nanosphere Inc. Luminex Corp. is paying $77mm ($1.70 per share; a 63% premium) in cash to acquire molecular diagnostics firm Nanosphere